Anavex Life Sciences Corp (AVXL)

[Anshu2]

If PR headline is ACCURATE, then we have a chance for approval (even if the analysis was only based on patients who had data at 48-weeks).

If there is indeed some half-lie and half-truth kinda situation -- then AVXL itself would brand this trial as POC/P2, and move to doing a P3.

I would give a 50-50 chance to the above two scenarios.